Report Description of the Japan OTC Medications for Cough, Cold & Flu Market Analysis
Research Scope and Assumption
- The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
- The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
- We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
- All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
- Inflation has not been accounted for in order to estimate and forecast the market
- Numbers may not add up due to rounding off
Reason to buy the report:
- Facilitate decision-making based on strong current and forecast data for Japan OTC Medications for Cough, Cold & Flu Market Analysis
- Develop strategies based on the latest regulatory framework
- Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
- Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Japan OTC Medications for Cough, Cold & Flu Market Analysis
- Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
- To strategically profile key players and comprehensively analyze their market shares and core competencies
- We have technically sound team which do a deep dive research and also provide strategy based consulting analysis
Japan OTC Medications for Cough, Cold & Flu Market Analysis Executive Summary
The Cold and Cough segment comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Market Size and Key Findings
The Japan OTC Medications for Cough, Cold & Flu Market Analysis size stood at around USD 1.8 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of -0.18% during the forecast period.
Revenue in the Cold & Cough Remedies segment amounts to US$1,808.73m in 2021. The market is expected to grow annually by -0.18% (CAGR 2021-2028).
Market Growth Drivers Analysis
The growth propelling factors of the Asia over-the-counter (OTC) drugs market are product innovations, high penetration in emerging countries, like India and China, and the inclination of pharmaceutical companies toward OTC drugs over prescription drugs. This can be attributed to the rapidly growing population and an increase in the disposable income of the population, which may add critical mass to the population available to access OTC medication. Along with new channels of accessibility in the emerging markets in retail outlets, supermarkets are contributing to the growth of the OTC medication market in Japan.
However, the lack of awareness among the population and incorrect self-diagnosis are expected to hamper the market growth.
COVID-19 impact on “Japan OTC Medications for Cough, Cold & Flu Market”
The entire supply chain from production to international trade has been impacted. The economic crisis due to COVID-19 is also impacting dietary supplements by disrupting distribution networks. The supplements, which are economically important, have a fragile supply chain and failure in any stage of the supply chain from farms to dealers, haulers and distributors to manufacturers-can disrupt the entire chain.
Notable Recent Deals
In April 2020, American Regent Inc., a US manufacturer of pharmaceuticals for human and veterinary use with manufacturing sites in New York and Ohio, acquired Daiichi Sankyo for an undisclosed amount. This acquisition increases American Regent’s production and provides the opportunity to explore other products to manufacture, allowing the company to continue to find innovative ways of responding to customer needs. Daiichi Sankyo is a pharmaceutical company with its corporate origin in Japan.
Healthcare Policies and Regulatory Landscape
Policy changes and Reimbursement scenario
- Japan has some very strong over-the-counter medication to fight colds and flus. Many cold, flu, and pain-relieving drugs contain caffeine or other stimulants to fight fatigue and allow you to remain alert through your entire work day even if your head is foggy and you can’t breathe out of your nose.
- It’s also very common to wear surgical masks if you’re sick (much to the fascination of many a visiting foreigner), but it’s mainly a courtesy to those around you, as even if you’re hacking and dribbling, you’re often still expected to come to work. A key exception is the flu: that stays home, whether you work in an office or in a school. With the population so tightly packed, every winter becomes a national battle to contain influenza!
- With that in mind, here are some popular cold and flu medicines the you can expect to see in people’s shopping baskets in Japan. These are mostly only available domestically, and be sure to check the ingredients if you ever plan to take any abroad—due to their constituents, some of these medicines are restricted overseas!